These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16338250)

  • 21. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
    Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
    J Am Coll Cardiol; 2008 Apr; 51(15):1448-54. PubMed ID: 18402899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of chronic kidney disease in long-term liver transplant recipients.
    de Boccardo G; Kim JY; Schiano TD; Maurette R; Gagliardi R; Murphy B; Emre S; Akalin E
    Transplant Proc; 2008 Jun; 40(5):1498-503. PubMed ID: 18589138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
    Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction.
    Vasu S; Gruberg L; Brown DL
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):701-5. PubMed ID: 17932900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment for chronic kidney disease service in high-risk patients at community health clinics.
    Patel HR; Pruchnicki MC; Hall LE
    Ann Pharmacother; 2005 Jan; 39(1):22-7. PubMed ID: 15546945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
    Serrano A; Huang J; Ghossein C; Nishi L; Gangavathi A; Madhan V; Ramadugu P; Ahya SN; Paparello J; Khosla N; Schlueter W; Batlle D
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):105-12. PubMed ID: 17200050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.
    Papafaklis MI; Naka KK; Papamichael ND; Kolios G; Sioros L; Sclerou V; Katsouras CS; Michalis LK
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):189-97. PubMed ID: 17253600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting.
    Völler H; Gitt A; Jannowitz C; Karoff M; Karmann B; Pittrow D; Reibis R; Hildemann S
    Eur J Prev Cardiol; 2014 Sep; 21(9):1125-33. PubMed ID: 23508927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients.
    Tsunoda K; Shimajiri Y; Morita S; Furuta M; Kadoya Y; Yamada S; Nanjo K; Sanke T
    Metab Syndr Relat Disord; 2009 Aug; 7(4):323-6. PubMed ID: 19558271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small, unilateral renal masses.
    Lucas SM; Nuss G; Stern J; Lotan Y; Sagalowsky AI; Cadeddu JA; Raj GV
    Cancer; 2008 Nov; 113(10):2681-6. PubMed ID: 18853420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.